0000805928-22-000067.txt : 20220603 0000805928-22-000067.hdr.sgml : 20220603 20220603161405 ACCESSION NUMBER: 0000805928-22-000067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220601 FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON JOHN CENTRAL INDEX KEY: 0001410781 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36046 FILM NUMBER: 22994534 MAIL ADDRESS: STREET 1: DENDREON CORPORATION STREET 2: 1301 2ND AVENUE CITY: SEATTLE STATE: WA ZIP: 98101 FORMER NAME: FORMER CONFORMED NAME: Johnson John H DATE OF NAME CHANGE: 20070827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axogen, Inc. CENTRAL INDEX KEY: 0000805928 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411301878 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: (386) 462-6817 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 FORMER COMPANY: FORMER CONFORMED NAME: AxoGen, Inc. DATE OF NAME CHANGE: 20111004 FORMER COMPANY: FORMER CONFORMED NAME: LECTEC CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 wf-form4_165428722800361.xml FORM 4 X0306 4 2022-06-01 0 0000805928 Axogen, Inc. AXGN 0001410781 JOHNSON JOHN 13631 PROGRESS BOULEVARD, SUITE 400 ALACHUA FL 32615 1 0 0 0 Employee Stock Option (right to purchase) 9.29 2022-06-01 4 A 0 11811 0 A 2032-06-01 Common Stock 11811.0 11811 D Restricted Stock Units 2022-06-01 4 A 0 6459 0 A Common Stock 6459.0 6459 D Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. John Johnson 2022-06-03